FORT LEE, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, will be hosting an Investor Meeting on Wednesday, December 13, 2006 at 9:00am at The Four Seasons Hotel in New York City. This presentation will be webcast in a listen only mode and can be accessed via the Internet at http://www.streetevents.com. A rebroadcast will be available on these websites from Wednesday, December 13, 2006 until midnight Friday, December 22, 2006.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock
Alpharma Inc.
CONTACT: Kathleen Makrakis, VP, Investor Relations of Alpharma Inc.,+1-201-228-5085, kathleen.makrakis@alpharma.com
